Budapest, Hungary

Szabolcs Kovács

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nicox S.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Szabolcs Kovács. Retrieved from https://idiyas.com/inventor/szabolcs-kovács

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Szabolcs Kovács: Innovator in Pharmaceutical Processes

Introduction

Szabolcs Kovács is a notable inventor based in Budapest, Hungary. He is currently associated with Nicox S.A., where he contributes to advancements in pharmaceutical processes. Although he has not yet been granted any patents, his work is significant in the field of drug formulation.

Latest Patent Applications

Szabolcs Kovács has been involved in the latest patent application titled "Industrial Process for the Preparation of Hexanoic Acid, 6-(Nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(Ethylamino)-7-Oxo-2-Hepten-1-YL]-3,5-Dihydroxycyclopentyl]-1-(2-Phenylethyl)-2-Propen-1-YL Ester and High Pure Product." This invention relates to a process for preparing a pharmaceutical grade compound efficiently through a one-pot reaction preparation step. The process includes the esterification of 15-OH bimatoprost and the removal of the boronate ester protecting group, followed by an efficient purification step. The invention also refers to high purity compounds that are substantially free of impurities and to ophthalmic pharmaceutical formulations containing these high purity compounds.

Conclusion

Szabolcs Kovács is an emerging inventor in the pharmaceutical industry, focusing on innovative processes that enhance drug formulation. His contributions, although not yet reflected in granted patents, show promise for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…